Evaluation of safety and health risk characterization of some baby foods in Ghana
View abstract on PubMed
Summary
This summary is machine-generated.Fungal contaminants, mycotoxins, and toxic metals were found in Ghanaian baby foods. Health risk assessments showed no adverse effects, but regular monitoring is crucial for infant safety.
Area Of Science
- Food safety and toxicology
- Microbiology
- Environmental health
Background
- Infant nutrition relies heavily on commercially prepared foods.
- Contamination of baby food with fungi, mycotoxins, and heavy metals poses a significant public health concern.
- Ghanaian markets have diverse baby food products requiring safety assessments.
Purpose Of The Study
- To assess fungal contamination, mycotoxin levels, and toxic metal presence in commercial baby foods sold in Ghana.
- To evaluate the associated health risks for infants consuming these products.
- To provide data supporting food safety regulations and monitoring.
Main Methods
- Standard microbiological protocols for fungal identification and enumeration.
- High-performance liquid chromatography with fluorescence detection (HPLC-FLD) for aflatoxins and Ochratoxin A (OTA).
- Atomic absorption spectrophotometry for determining copper (Cu), lead (Pb), arsenic (As), cadmium (Cd), mercury (Hg), and chromium (Cr).
Main Results
- Fungal contaminants were present in all samples (3.2–4.52 log CFU/g), with yeasts, Aspergillus, and Fusarium species being most common.
- Aflatoxins ranged from 0.315–11.446 µg/kg and Ochratoxin A from 1.991–2.510 µg/kg.
- Trace levels of lead, cadmium, mercury, arsenic, and copper were detected; no significant health risks were identified based on EDI and ILCR values.
Conclusions
- Commercial baby foods in Ghana harbor fungal contaminants and mycotoxins, though current levels pose no immediate health risk.
- Continuous monitoring of baby food contaminants is essential to safeguard infant health.
- Further research into sources of contamination and mitigation strategies is recommended.
Related Concept Videos
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

